Your browser doesn't support javascript.
loading
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
Marzolini, Catia; Kuritzkes, Daniel R; Marra, Fiona; Boyle, Alison; Gibbons, Sara; Flexner, Charles; Pozniak, Anton; Boffito, Marta; Waters, Laura; Burger, David; Back, David J; Khoo, Saye.
Affiliation
  • Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel and University of Basel, Basel, Switzerland.
  • Kuritzkes DR; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Marra F; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Boyle A; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Gibbons S; Department of Pharmacy, National Health Service Greater Glasgow and Clyde, Glasgow, UK.
  • Flexner C; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Pozniak A; Department of Pharmacy, National Health Service Greater Glasgow and Clyde, Glasgow, UK.
  • Boffito M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Waters L; Divisions of Clinical Pharmacology and Infectious Diseases, School of Medicine and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Burger D; Chelsea and Westminster Hospital National Health Service Foundation Trust, London, UK.
  • Back DJ; London School of Hygiene and Tropical Medicine, London, UK.
  • Khoo S; Chelsea and Westminster Hospital National Health Service Foundation Trust, London, UK.
Clin Pharmacol Ther ; 112(6): 1191-1200, 2022 12.
Article de En | MEDLINE | ID: mdl-35567754

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ritonavir / Traitements médicamenteux de la COVID-19 Type d'étude: Guideline Limites: Humans Langue: En Journal: Clin Pharmacol Ther Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ritonavir / Traitements médicamenteux de la COVID-19 Type d'étude: Guideline Limites: Humans Langue: En Journal: Clin Pharmacol Ther Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: États-Unis d'Amérique